Chimerix
Home
about Chimerix
About Chimerix
Strategy
Licensing Opportunities
Commitment
Management Team
Board of Directors
Scientific Advisory Board
Clinical Advisory Board
Investors
Therapeutic Programs
Pipeline
CMX001
dsDNA viruses
Smallpox
CMX001 Publications & Presentations
CMX157
HIV
CMX157 Publications & Presentations
Research Programs
Clinical Trials
Scientific Foundation
News & Resources
News Releases
Presentations
Careers
Working at Chimerix
Opportunities
Contact Us
Scientific Foundation
Scientific Foundation
Lipid Antiviral Conjugate Technology
Chimerix Chemical Library
Patents
Home
Scientific Foundation
Featured News & Events
Chimerix Antiviral Compound CMX001 Meets CMV Phase 2 Primary Endpoint in Allogeneic Hematopoietic Stem Cell Transplant Recipients
Chimerix Announces Presentation of Final Data from CMX001 Ph 2 Trial in Prophylaxis of CMV in Hematopoietic Stem Cell Transplant Patients
Chimerix to Present at Upcoming Lazard and Piper Jaffray Healthcare Conferences
Chimerix Announces Late-Breaker Presentation at 51st ICAAC Annual Meeting
